Publications
Publications 176 - 200 de 33557
| Titre | DOI |
|---|---|
|
5-fluorouracil therapeutic drug monitoring: Update and recommendations of the STP-PT group of the SFPT and the GPCO-Unicancer F. Lemaitre; F. Goirand; M. Launay; E. Chatelut; J.C. Boyer; A. Evrard; M.N. Paludetto; R. Guilhaumou; J. Ciccolini; A. Schmitt 2018 |
10.1016/j.bulcan.2018.06.008 |
|
5-year follow-up of spinal and sacroiliac MRI abnormalities in early axial spondyloarthritis: data from the DESIR cohort Q. Madari; A. Sepriano; S. Ramiro; A. Molto; P. Claudepierre; D. Wendling; M. Dougados; D. van der Heijde; F.A. Van Gaalen 2020 |
10.1136/rmdopen-2019-001093 |
|
5-year follow-up of the safety, tolerability and efficacy of subcutaneous trastuzumab for the adjuvant treatment of HER2-positive early breast cancer. Results from the SafeHER Phase III trial J. Gligorov; X. Pivot; B. Ataseven; M. De Laurentiis; A. Llombart; K.H. Jung; A. Manikhas; H.A. Azim; A. Alexandrou; K. Gupta; L. Herraez-Baranda; N. Tosti; E. Restuccia 2021 |
|
|
5-year follow-up of the safety, tolerability and efficacy of subcutaneous trastuzumab for the adjuvant treatment of HER2-positive early breast cancer. Results from the SafeHER Phase III trial J. Gligorov; X. Pivot; B. Ataseven; M. De Laurentiis; A. Llombart; K.H. Jung; A. Manikhas; H.A. Azim; A. Alexandrou; K. Gupta; L. Herraez-Baranda; N. Tosti; E. Restuccia 2021 |
|
|
5-YEAR OVERALL SURVIVAL AND PROGRESSION-FREE SURVIVAL IN MULTIPLE MYELOMA BY LINE OF TREATMENT FROM THE FRENCH HEMATOLOGIC MALIGNANCY REGISTRY M. Mounier; S. Gauthier; Mayandi; X. Troussard; A. Monnereau; C. Guilhaume; F. Suzan; C. Blachier-Poisson; N. Despiegel 2016 |
10.1016/j.jval.2016.09.2374 |
|
5-year overall survival of early breast cancer during pregnancy: A multicenter French case control study L. Vanlemmens; A. Ploquin; S. Delaloge; R. Rouzier; A. Lesur; J.S. Frenel; C. Loustalot; T. Bachelot; M. Provansal; J.M. Ferrero; F. Coussy; M. Debled; P. Kerbrat; A. Vinceneux; A. Djelila; M. Baron; S. Jebert; E. Decoupigny; E. Tresch; J. Bonneterre 2016 |
10.1158/1538-7445.SABCS15-P1-07-02 |
|
5azadC treatment upregulates miR-375 level and represses HPV16 E6 expression A. Morel; A. Baguet; J. Perrard; C. Demeret; E. Jacquin; D. Guenat; C. Mougin; J.L. Pretet 2017 |
10.18632/oncotarget.17575 |
|
6 An atypical late-onset case of homozygous ATM variant supported by a complex molecular mechanism of mosaic uniparental isodisomy S. Nambot 2020 |
10.1016/j.annonc.2020.08.2217 |
|
6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial X. Pivot; G. Romieu; M. Debled; Y. Pierga; P. Kerbrat; T. Bachelot; A. Lortholary; M. Espie; P. Fumoleau; D. Serin; J.P. Jacquin; C. Jouannaud; M. Rios; S. Abadie-Lacourtoisie; L. Venat-Bouvet; L. Cany; S. Catala; D. Khayat; L. Gambotti; I. Pauporte; C. Faure-Mercier; S. Paget-Bailly; J. Henriques; J.Marie Grouin; P.H.A.R.E.Trial Investigators 2019 |
10.1016/S0140-6736(19)30653-1 |
|
6-DoF Full Robotic Calibration Based on 1-D Interferometric Measurements for Microscale and Nanoscale Applications H. Bettahar; O. Lehmann; C. Clevy; N. Courjal; P. Lutz 2022 |
10.1109/TASE.2020.3031856 |
|
6-phase soft-switching Interleaved Boost Converter based on SiC semiconductor for Fuel Cell Vehicles H. Wang; A. Gaillard; D. Hissel 2016 |
|
|
6-Polyamino-substituted quinolines: synthesis and multiple metal (Cu-II, Hg-II and Zn-II) monitoring in aqueous media A.S. Abel; A.D. Averin; A.V. Cheprakov; V.A. Roznyatovsky; F. Denat; A. Bessmertnykh-Lemeune; I.P. Beletskaya 2019 |
10.1039/c9ob00259f |
|
60 dB Dynamic Range Single-Shot Spectral Measurements of Spontaneous Modulation Instability M. Narhi; J. Toivonen; J.M. Dudley; G. Genty 2017 |
|
|
67P/Churyumov-Gerasimenko, a Jupiter family comet with a high D/H ratio K. Altwegg; H. Balsiger; A. Bar-Nun; J.J. Berthelier; A. Bieler; P. Bochsler; C. Briois; U. Calmonte; M. Combi; J. De Keyser; P. Eberhardt; B. Fiethe; S. Fuselier; S. Gasc; T.I. Gombosi; K.C. Hansen; M. Haessig; A. Jaeckel; E. Kopp; A. Korth; L. Leroy; U. Mall; B. Marty; O. Mousis; E. Neefs; T. Owen; H. Reme; M. Rubin; T. Semon; C.Y. Tzou; H. Waite; P. Wurz 2015 |
10.1126/science.1261952 |
|
6q16.3q23.3 duplication associated with Prader-Willi-like syndrome L. Desch; N. Marle; A.L. Mosca-Boidron; L. Faivre; M. Eliade; M. Payet; C. Ragon; J. Thevenon; B. Aral; S. Ragot; A. Ardalan; N. Dhouibi; C. Bensignor; C. Thauvin-Robinet; S.El Chehadeh; P. Callier 2015 |
10.1186/s13039-015-0151-6 |
|
7 beta-hydroxycholesterol-induced cell death, oxidative stress, and fatty acid metabolism dysfunctions attenuated with sea urchin egg oil A. Zarrouk; Y. Ben Salem; J. Hafsa; R. Sghaier; B. Charfeddine; K. Limem; M. Hammami; H. Majdoub 2018 |
10.1016/j.biochi.2018.06.027 |
|
7-Ketocholesterol and 7 beta-hydroxycholesterol: In vitro and animal models used to characterize their activities and to identify molecules preventing their toxicity A. Vejux; D. Abed-Vieillard; K. Hajji; A. Zarrouk; J.J. Mackrill; S. Ghosh; T. Nury; A. Yammine; M. Zaibi; W. Mihoubi; H. Bouchab; B. Nasser; Y. Grosjean; G. Lizard 2020 |
10.1016/j.bcp.2019.113648 |
|
7-Ketocholesterol is increased in the plasma of X-ALD patients and induces peroxisomal modifications in microglial cells: Potential roles of 7-ketocholesterol in the pathophysiology of X-ALD T. Nury; A. Zarrouk; K. Ragot; M. Debbabi; J.M. Riedinger; A. Vejux; P. Aubourg; G. Lizard 2017 |
10.1016/j.jsbmb.2016.03.037 |
|
7-Ketocholesterol: Effects on viral infections and hypothetical contribution in COVID-19 I. Ghzaiel; K. Sassi; A. Zarrouk; T. Nury; M. Ksila; V. Leoni; B. Bouhaouala-Zahar; S. Hammami; M. Hammami; J.J. Mackrill; M. Samadi; T. Ghrairi; A. Vejux; G. Lizard 2021 |
10.1016/j.jsbmb.2021.105939 |
|
7-Ketocholesteroland 7 beta-Hydroxycholesterol-Induced Peroxisomal Disorders in Glial, Microglial and Neuronal Cells: Potential Role in Neurodegeneration 7-ketocholesterol and 7 beta-hydroxycholesterol-Induced Peroxisomal Disorders and Neurodegeneration T. Nury; A. Yammine; F. Menetrier; A. Zarrouk; A. Vejux; G. Lizard 2020 |
10.1007/978-3-030-60204-8_3 |
|
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age M. Piccart; L.J. van `t Veer; C. Poncet; J.M.N.Lope Cardozo; S. Delaloge; J.Y. Pierga; P. Vuylsteke; E. Brain; S. Vrijaldenhoven; P.A. Neijenhuis; S. Causeret; T.J. Smilde; G. Viale; A.M. Glas; M. Delorenzi; C. Sotiriou; I.T. Rubio; S. Kummel; G. Zoppoli; A.M. Thompson; E. Matos; K. Zaman; F. Hilbers; D. Fumagalli; P. Ravdin; S. Knox; K. Tryfonidis; A. Peric; B. Meulemans; J. Bogaerts; F. Cardoso; E.J.T. Rutgers 2021 |
10.1016/S1470-2045(21)00007-3 |
|
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer F. Cardoso; L.J. van't Veer; J. Bogaerts; L. Slaets; G. Viale; S. Delaloge; J.Y. Pierga; E. Brain; S. Causeret; M. DeLorenzi; A.M. Glas; V. Golfinopoulos; T. Goulioti; S. Knox; E. Matos; B. Meulemans; P.A. Neijenhuis; U. Nitz; R. Passalacqua; P. Ravdin; I.T. Rubio; M. Saghatchian; T.J. Smilde; C. Sotiriou; L. Stork; C. Straehle; G. Thomas; A.M. Thompson; J.M. van der Hoeven; P. Vuylsteke; R. Bernards; K. Tryfonidis; E. Rutgers; M. Piccart; M.I.N.D.A.C.T. Investigators 2016 |
10.1056/NEJMoa1602253 |
|
7000-year human legacy of elevation-dependent European fire regimes B. Vanniere; O. Blarquez; D. Rius; E. Doyen; T. Bruecher; D. Colombaroli; S. Connor; A. Feurdean; T. Hickler; P. Kaltenrieder; C. Lemmen; B. Leys; C. Massa; J. Olofsson 2016 |
10.1016/j.quascirev.2015.11.012 |
|
7107 Islands Y. Boquet 2017 |
10.1007/978-3-319-51926-5_2 |
|
8-Formylophiopogonanone B induces ROS-mediated apoptosis in nasopharyngeal carcinoma CNE-1 cells Yjing Zhang; Zlin Mu; P. Deng; Ydan Liang; Lchuan Wu; Lling Yang; Z. Zhou; Zping Yu 2021 |
10.1093/toxres/tfab087 |